Mayinglong Pharmaceutical (600993.SS)

Market Performance

  • Trading session: The stock traded flat (0 %) during a 24‑hour period ending at 07:42 AM Central Europe on Friday 23 May 2026.
  • Current price: CNH 24.34 on major exchanges.
  • Volume: Approximately CNH 158.5 million was traded in the last 24 hours.
  • Supply: 431.1 million shares are available for trading.
  • Market capitalisation: CNH 1.4 billion.
  • Year‑to‑date change: Up 4.5 % since the end of the previous month.
  • Simple moving average (200 days): CNH 23.32.
  • 52‑week range: Highest price of CNH 30.18 on 12 December 2025; lowest price of CNH 21.22 on 1 July 2026.

Technical Indicators

IndicatorValue
Current priceCNH 24.34
200‑day SMACNH 23.32
52‑week highCNH 30.18
52‑week lowCNH 21.22

Peer Comparison (Last 24 Hours)

CompanySymbolChangeCurrent priceMarket capP/E ratio
Many Idea Cloud6696.HK0 %HKD 2.94HKD 1.8 bn–
Henan Yuguang Gold & Lead600531.SS0 %CNH 9.94CNH 1.7 bn12.94
Shandong Weigao Gp Medical‑h1066.HK+0.31 %HKD 3.20HKD 1.8 bn8.89
Shenzhen Info000070.SZ0 %CNH 13.18CNH 1.7 bn–
Shanghai Feilo Acoustic600651.SS0 %CNH 4.68CNH 1.7 bn360.53

Company Overview

Mayinglong Pharmaceutical Group Co. Ltd. is a Chinese health‑care company headquartered in Wuhan. The firm designs, manufactures, and markets a range of pharmaceutical products, including hemorrhoid plasters, traditional Chinese medicines, and oral tablets. It also distributes medical equipment and health‑food items. The company is listed on the Shanghai Stock Exchange and conducted its initial public offering on 23 April 2004. Further information is available on the corporate website, www.mayinglong.cn .